• A Madison Avenue makeover: Omnicom’s $9 billion merger with IPG is complete

    omnicom john wren
    John Wren's Omnicom has completed its takeover of fellow advertising giant IPG.

    • Advertising giant Omnicom has completed its acquisition of Interpublic Group.
    • The merger creates the largest advertising agency by revenue.
    • Agency holding companies face challenges from emerging tech like AI and new competitors.

    Madison Avenue's makeover is taking shape.

    Omnicom officially completed its acquisition of Interpublic Group on Wednesday, in a $9 billion all-stock deal that creates the largest advertising agency holding company by revenue. The combined company will generate annual revenue exceeding $25 billion, Omnicom said.

    The agency mega-merger, first announced in December, creates a portfolio that unites creative networks such as BBDO and McCann, media buying agencies including OMD and Initiative, and the Omni and Acxiom data platforms.

    In a statement, Omnicom CEO John Wren, who will lead the merged company, said the acquisition marks a "defining moment for our company and our industry."

    "With the completion of the deal, Omnicom is setting a new standard for modern marketing and sales leadership — creating stronger brands, delivering superior business outcomes, and driving sustainable growth," Wren said.

    Omnicom said it will announce its full leadership team on December 1.

    The deal reflects the changing fortunes of Madison Avenue. The holding company landscape, once referred to as the big six — Omnicom, IPG, WPP, Publicis Groupe, Dentsu, and Havas — has now become five.

    One of the theories behind the deal is that being bigger is the best strategy. By merging, Omnicom-IPG can reduce operating costs by consolidating systems, while also leveraging its collective client ad spending from the world's biggest brands to negotiate better deals with media owners and tech platforms.

    However, some industry insiders have said that the deal also highlights how the power of holding companies is being challenged by the emergence of new technologies and competitors. Technology such as generative AI has made it easier for marketers to in-house some of the work they used to outsource to agencies. Newer entrants to the space, including consulting firms, private equity-backed ad networks, and independent agencies, are all vying for marketers' budgets. Marketers, facing macroeconomic pressures such as tariffs and high interest rates, are pushing agencies to produce more work at the same or lower budgets.

    "The industry in general is under attack because clients are finding more efficient ways to make content at scale," said Greg Paull, president of global growth at the media advisory firm MediaSense.

    Even the sector's star performer, Publicis, buoyed by several significant new business wins in recent months, including Mars and Coca-Cola's North American media account, has seen its market value drop by around 19% year-to-date.

    Omnicom's share price has also fallen sharply since the IPG deal was first announced late last year, causing the transaction to drop from an initial valuation of roughly $13 billion. Omnicom shareholders will own around 61% of the combined company, with Interpublic shareholders owning about 39%.

    Agency layoffs have been a constant at companies across the advertising sector. Steve Boehler of the consulting firm Mercer Island Group expects the Omnicom merger will lead to 20,000 job cuts at the combined company, including the layoffs IPG has already made this year.

    Industry analysts anticipate further ad agency consolidation in the coming months.

    Japan-based Dentsu is restructuring its international business — everything outside Japan — which could include a potential sale. Speculation has swirled around the future of WPP amid a recent run of poor financial performance, with newly appointed CEO Cindy Rose tasked with bringing about a turnaround. Earlier this month, media reports suggested Havas was eyeing a bid for WPP. Havas CEO Yannick Bolloré later said in an internal memo, "We are not in discussions with WPP." Industry insiders and analysts have also predicted that advertising companies will continue to be a target for private-equity giants and consulting firms.

    As Omnicom works through the intricacies of its merger to deliver the margins expected by investors, competitors could look to seize the opportunity.

    "It'll look like an interesting time where there are fewer big holding company brands, leaving space in the market for PE-backed and large successful independents to continue to merge and do a better job of attacking that middle-market where there's so much business that isn't getting senior-level attention from the holding companies," Boehler said.

    Read the original article on Business Insider
  • The next wave of ASX tech winners to buy before 2026

    A group of six work colleagues gather around a computer in an office situation and discuss something on the screen as one man points and others look on with interest

    If there’s one corner of the market that consistently produces long-term wealth, it is technology.

    Sure, 2025 has been volatile for ASX tech stocks, but history shows that the best time to buy future winners is often during periods of uncertainty, not after the recovery has already happened.

    So, if you are looking to position your portfolio for the next phase of tech-led growth heading into 2026, it could be worth checking out the three ASX tech stocks listed below that analysts rate as buys:

    Megaport Ltd (ASX: MP1)

    The first ASX tech stock that could be a long term winner is Megaport.

    Its global software-defined network allows businesses to connect directly to the world’s biggest cloud providers, including Amazon Web Services, Google Cloud and Microsoft Azure, with speed and flexibility traditional networks simply can’t match.

    As enterprises accelerate their shift toward hybrid cloud environments and AI workloads require faster, more flexible networking, Megaport sits in the sweet spot of a long-term structural trend. It has also just announced a key acquisition in India, which significantly boosts its addressable market.

    Earlier this week, the team at Morgans upgraded Megaport’s shares to a buy rating with a $17.00 price target.

    NextDC Ltd (ASX: NXT)

    The AI boom isn’t slowing down, and NextDC is one of the clearest beneficiaries on the ASX. Its network of hyperscale data centres is experiencing strong demand from cloud providers, enterprise customers, and AI-driven infrastructure requirements.

    NextDC continues to invest heavily in new facilities, expand its footprint and secure long-term customer commitments. As data usage, cloud adoption and AI modelling continue to surge, the company is positioned for years of sustained growth.

    Macquarie is a fan of the data centre operator. It has an outperform rating and $20.90 price target on its shares.

    Siteminder Ltd (ASX: SDR)

    A third ASX tech share that could be destined for big things is Siteminder. It has established itself as one of Australia’s global software-as-a-service success stories.

    Its cloud-based hotel commerce platform now serves tens of thousands of accommodation providers worldwide, helping them manage bookings, pricing, distribution and payments through a single interface.

    The company continues to benefit from the global shift towards digital hotel management. Larger properties are upgrading outdated systems and smaller operators are moving online for the first time.

    With strong annualised recurring revenue, improving margins and a massive international footprint still to penetrate, Siteminder is shaping up as a long-term compounder that the market isn’t fully appreciating yet.

    Macquarie is also a fan of this one. It has an outperform rating and $8.55 price target on its shares.

    The post The next wave of ASX tech winners to buy before 2026 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Megaport right now?

    Before you buy Megaport shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Megaport wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Megaport and Nextdc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, Megaport, and SiteMinder. The Motley Fool Australia has positions in and has recommended Macquarie Group and SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 3 reasons Telstra shares are a screaming buy right now!

    A cute little kid in a suit pulls a shocked face as he talks on his smartphone.

    Telstra Group Limited (ASX: TLS) shares closed 0.61% lower on Wednesday afternoon, at $4.92 a piece. For the month, the shares are 0.41% higher, and they’re now 25.83% higher than this time last year.

    Right now, I believe the leading Australian telecommunications and technology company is a screaming buy. Here’s why.

    1. Telstra’s dividends provide a reliable passive cashflow

    Telstra has a reputation for handing out large and regular fully franked dividend payments to its shareholders. It’s known for being one of the most reliable options on the index, which is great for any investor seeking a passive income. Telstra has paid out a steadily increasing dividend yield for several years, including during the COVID pandemic period.

    Commsec analysts have forecast that Telstra will pay an annual dividend per share of around 20 cents in FY26. That translates to a grossed-up dividend yield of 5.6%, including franking credits. 

    UBS thinks this could be even higher. The broker is currently forecasting that Telstra could pay an annual dividend per share of 21 cents in FY26 (with further dividend increases in the coming years). This implies the company could deliver a cash dividend yield of 4.2% and a grossed-up dividend yield of 6%, including franking credits, in FY26.

    2. It’s a defensive stock

    A defensive stock is a company that tends to perform steadily, regardless of the stage of the economic cycle. Typically, this is because it provides essential goods or services that people need, regardless of the state of the economy. Telstra falls into this category because, in my view, mobile and internet connections in households and businesses is no longer a luxury but a necessity. 

    This means that if investors hold some defensive stocks, such as Telstra shares, in their share portfolio, it can help hedge against potential risk. It may even act as a safety net in the event of a share market crash. In my view, this is a compelling reason to hold Telstra shares in your portfolio. 

    3. There’s a good potential upside for Telstra shares

    Telstra has heavily invested in its 5G network over the past few years, which has helped the company boost its subscriber base and grow its market share. 

    Tradingview data shows that, out of 9 analysts, 3 have a strong buy rating on Telstra shares. The maximum target price for the stock is $5.40 per share, which, at the time of writing, implies a potential 9.76% upside over the next 12 months.

    The post 3 reasons Telstra shares are a screaming buy right now! appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Telstra Corporation Limited right now?

    Before you buy Telstra Corporation Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Telstra Corporation Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Which ASX dividend shares are brokers recommending to clients?

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

    Fortunately for income investors in this low interest rate environment, there are many options for them on the Australian share market.

    Two ASX dividend shares that brokers think are in the buy zone right now are listed below. Here’s what they are recommending to clients:

    Flight Centre Travel Group Ltd (ASX: FLT)

    Flight Centre could be an ASX dividend share to buy this month.

    That’s the view of analysts at Morgans, who believe that it is worth holding very tightly to this travel agent’s shares.

    The broker believes that when trading conditions return to normal, the upside could be significant for investors. It said:

    FLT’s FY25 result was broadly in line with its recent update. Corporate was weaker than expected while Leisure and Other were stronger. FLT’s guidance for a flat 1H26 was stronger than we expected however it was weaker than consensus. Earnings growth is expected to accelerate in the 2H26 from an improvement in macro-economic conditions and internal business improvement initiatives. We have made minor upgrades to our forecasts.

    We are buyers of FLT during this period of short-term uncertainty and share price weakness because when operating conditions ultimately improve, both its earnings and share price leverage to the upside will be material.

    As for income, Morgans is expecting fully franked dividends of 51 cents per share in FY 2026 and then 58 cents per share in FY 2027. Based on the current Flight Centre share price of $12.71, this would mean dividend yields of 4% and 4.6%, respectively.

    The broker has a buy rating and $15.65 price target on its shares.

    GDI Property Group Ltd (ASX: GDI)

    Another ASX dividend share that has been given the thumbs up by analysts is GDI Property Group. It is an integrated, internally managed commercial property investor.

    Bell Potter is positive on the company and highlights the massive discount that its shares are trading on at present. The broker explains:

    No change to our Buy recommendation. GDI continues to trade at a significant -41% discount to NTA which reflects no value for its FM OpCo, and while the Perth office market recovery could be a ‘slow burn’ with early leasing wins working through for GDI, we do still see upside from current levels which drops straight through to FFO gains

    In respect to dividends, the broker is forecasting payouts of 5 cents per share in both FY 2026 and FY 2027. Based on its current share price of 65.5 cents, this would mean dividend yields of 7.6% for both years.

    Bell Potter has a buy rating and 85 cents price target on its shares.

    The post Which ASX dividend shares are brokers recommending to clients? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Flight Centre Travel Group Limited right now?

    Before you buy Flight Centre Travel Group Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Flight Centre Travel Group Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Should I buy Sigma Healthcare shares for the Chemist Warehouse exposure?

    A senior pharmacist talks to a customer at the counter in a shop.

    Owning Sigma Healthcare Ltd (ASX: SIG) shares means gaining exposure to several healthcare businesses, including Chemist Warehouse. After dropping 7% since the November peak, I think it’s worth asking whether the business is a buy-the-dip opportunity.

    There are several other businesses in the portfolio, including Amcal and Discount Drug Stores. It’s also a wholesale supplier to other pharmacies.

    Chemist Warehouse has pharmacies in several other countries, including New Zealand, Ireland and Dubai. It’s also working on Chinese locations.

    Let’s take a look at whether this is a good time to invest in Sigma Healthcare shares.

    Expert views on Sigma Healthcare shares

    Broker UBS currently has a buy rating on the business because Chemist Warehouse is on course to drive “multi-year double-digit” earnings per share (EPS) growth.

    UBS notes that the health and beauty market is growing at an estimated 6% per year, and Chemist Warehouse is expected to deliver continued market share gains.

    The broker said that the company’s sales growth, driven by both like-for-like (LFL) sales growth and store network expansion, is delivering operating leverage. The operating profit (EBIT) margin is also benefiting from a rising gross profit margin and the ongoing synergies between Chemist Warehouse and the rest of the Sigma Healthcare business.

    UBS believes the Sigma Healthcare share price and relatively high price/earnings (P/E) ratio are justified because of the potential EPS growth and the fact that it’s capital-light, making the risk-reward dynamic attractive.

    Analysts at UBS predict Chemist Warehouse’s LFL sales growth could accelerate from 10.9% in FY25 to 13.2% in FY26, then a further 10.2% LFL growth in FY27. After that, high single-digit LFL sales growth is expected for FY30.

    Tailwinds that could drive the industry and the company

    Sigma Healthcare shares could benefit from both industry tailwinds and ongoing market share gains in the years to come, according to UBS.

    The broker said there are multiple industry tailwinds, including:

    (1) ageing population; (2) health prioritisation; (3) higher value medicines; and (4) greater category participation and spend per consumer in health & beauty.

    On the prospect of a higher market share, UBS said:

    Chemist Warehouse is likely to continue to gain share as an everyday retailer given its leadership in price & range, regulatory advantages, compliance and omni-channel capabilities. Chemist Warehouse is forecast to maintain 33 store openings as per its historical average due to: (1) franchisor support; (2) acquisitions; and (3) international growth in existing and possibly new markets.

    Price target on Sigma Healthcare shares

    UBS currently has a price target of $3.40 on the ASX healthcare share, implying a potential rise of 16% over the next year. The broker is also expecting the company to pay an annual dividend of 4 cents per share in the 2026 financial year.

    The post Should I buy Sigma Healthcare shares for the Chemist Warehouse exposure? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Sigma Healthcare right now?

    Before you buy Sigma Healthcare shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sigma Healthcare wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 great ASX shares I’d buy for diversification

    a man's hand places a white egg into a basket of similar white eggs.

    It’s usually a good idea not to put all of one’s investment eggs in one basket. Different ASX shares can provide investors with both good returns and exposure to a variety of sectors, enabling diversification.

    Owning a portfolio of just two businesses isn’t very diversified. But owning two investments that each have a diversified portfolio could be a smart move, particularly if they provide exposure to assets that Aussies don’t typically own.

    In this article, I will discuss one exchange-traded fund (ETF) and one ASX share that’s best known as a listed investment company (LIC).

    Vanguard FTSE Europe Shares ETF (ASX: VEQ)

    There are several different markets that investors can invest in, including the US stock market, the global stock market, emerging markets, Asian shares, and others.

    European shares could be an underrated option for Aussie investors who don’t necessarily want (more) exposure to some areas of the global share market.  

    The VEQ ETF provides exposure to companies listed in major European markets.

    It has more than 1,200 holdings, which is a lot of businesses and good diversification. Some of the world’s most compelling companies are in the portfolio, including ASML, SAP, Astrazeneca, HSBC, Nestle, Roche, Novartis, Shell, Siemens and LVMH.

    The returns of the VEQ ETF have been solid – over the last three years, it has returned an average annual rate of 19%, and in the past five years, it has returned an average annual rate of 14.5%. Of course, past performance is not a guarantee of future returns.

    I should note that I’m calling this an ASX share because it’s about investing in shares, and we can buy it on the ASX.

    I view its sector allocation as more compelling than the ASX 200, with the VEQ ETF having the following weightings: financials (23.1%), industrials (19.8%), healthcare (12.9%), consumer discretionary (9.4%), technology (8.6%), consumer staples (8%), energy (5.1%), basic materials (4.5%), utilities (4.4%), telecommunications (2.7%) and real estate (1.6%).

    Finally, I’ll note the country allocation is pleasing because of how many markets it’s invested in such as the UK (23.3% of the portfolio), France (14.5%), Germany (13.9%), Switzerland (13.7%), the Netherlands (7%), Sweden (5.6%), Spain (5.5%), Italy (5.4%), Denmark (2.9%), Belgium (1.8%), Finland (1.8%), Norway (1.2%) and more.

    MFF Capital Investments Ltd (ASX: MFF)

    MFF has spent most of its life as a pure LIC, but it recently acquired a funds management business called Montaka, so it now has an operational element (and a broader investment research team).

    The main value of the business is based on its portfolio of mostly international shares. Some of its largest holdings include Mastercard, Visa, Alphabet, Amazon, Meta Platforms and Microsoft.  

    The ASX share has the flexibility to invest in various markets and different-sized businesses. For example, it recently invested in L1 Group Ltd (ASX: L1G), a promising fund manager that is significantly smaller than Microsoft and the other major tech companies.

    It has been trading at a discount of around 10% to its net tangible assets (NTA) in recent times, which I believe is an appealing valuation for purchase.

    With a growing dividend, there’s a lot to like about the business for diversification and potential returns.

    The post 2 great ASX shares I’d buy for diversification appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Mff Capital Investments right now?

    Before you buy Mff Capital Investments shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mff Capital Investments wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    HSBC Holdings is an advertising partner of Motley Fool Money. Motley Fool contributor Tristan Harrison has positions in Mff Capital Investments. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ASML, Alphabet, Amazon, Mastercard, Meta Platforms, Microsoft, and Visa. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended AstraZeneca Plc, HSBC Holdings, Nestlé, Roche Holding AG, and SAP and has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended ASML, Alphabet, Amazon, Mastercard, Meta Platforms, Mff Capital Investments, Microsoft, and Visa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Should I buy CSL shares in December?

    Medical workers examine an xray or scan in a hospital laboratory.

    The CSL Ltd (ASX: CSL) share price decline of 35% this year (at the time of writing) is one of the biggest among ASX blue-chip shares in 2025.

    While the company has decades of delivering growth under its belt, the market now seems more cautious about its growth prospects in the near future.

    The US healthcare industry looks challenging under the relatively new US administration, with a shift in focus on vaccines and other healthcare areas. As a major player in the vaccine space, this seems like a headwind for CSL’s medium-term growth. Other areas of CSL’s business may also not grow as fast as previously hoped.

    But the significant decline of the CSL share price may mean the business is undervalued. Let’s take a look at the potential for capital gains.

    CSL share price potential

    Earlier this month, CSL held an investor day, with UBS seeing some mixed numbers.

    Seqirus (CSL’s vaccine business) is expected to see sales fall 15% in FY26, which “reflects another significant drop in US vaccination rates, partly offset by market share gains in 65+ years in Europe.”

    UBS believes there is scope for a meaningful US recovery over the medium term, with flu doses in FY26 around 30% below pre-COVID levels, compared to other large markets, which are stabilising at pre-COVID levels. But, that probably requires “greater doctor support coupled with political pressure from a higher disease burden”, with CSL not assuming a recovery in the next couple of financial years.

    The broker then said:

    The largest long-term opportunity [is] through new aTIVc (combined cell based and adjuvant vaccine) which should receive European regulatory approval in 2026, while a reducing number of COVID vaccinations limits the upside of its future mRNA product. Valuation: $275/share (unchanged) in 12 months’ time.

    UBS is expecting a 100 basis point (1%) increase of CSL’s net profit after tax (NPAT) margin across FY27 and FY28, which helps take the potential net profit growth to high single digits.

    The broker also points out that CSL has a cost-saving target of US$550 million, which could assist earnings.

    Areas such as operating efficiencies, targeted gross cost savings in research and development, commercial efficiencies, and overheads could help the business reduce its addressable manufacturing costs by 11% by FY28.

    CSL thinks it’s well-positioned to deal with US tariffs and ‘most favoured nation’ (MFN – cheaper healthcare costs for US customers) issues, thanks to the likely plasma exclusion and CSL’s growing US investment.

    UBS rating on the ASX healthcare share

    The broker has a buy rating on the business, with a price target of $275. That implies a possible rise of 50% over the next year from where it is today.

    UBS is projecting profit growth each year between FY26 and FY30. But the business may need to deliver on earnings expectations to justify a strong double-digit capital gain over the next 12 months.

    The post Should I buy CSL shares in December? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CSL right now?

    Before you buy CSL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Which ethically focussed ASX ETFs have performed the best this year?

    A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today

    One of the many positives of ASX ETFs is the ability to gain exposure to niche themes or sectors. 

    A trend that is becoming increasingly prevalent is the focus on ESG investing.

    ESG investing is based on environmental, social, and governance considerations. 

    It is becoming increasingly important for investors to aim not only for financial returns but also to impact the world through their investment choices positively.

    For example, this could mean focusing on climate-positive companies. 

    Or, it can also materialise by actively excluding companies engaged in harmful industries. 

    This is called negative screening – excluding companies involved in industries like fossil fuels, weapons, tobacco, gambling, etc. 

    Fortunately for ESG investors, there are numerous ASX ETFs that group companies aligned with these themes.

    Let’s look at the funds that have brought the best returns in 2025. 

    iShares Core MSCI World All Cap ETF (ASX: IWLD)

    ESG investing can come in very different forms. For investors looking to add ESG exposure to their portfolio, it’s vital to dig into each fund to understand the screening process and underlying holdings. 

    This is important because where ASX ETF providers draw the line on an ethical company may differ from your own. 

    The ethos behind the iShares Core MSCI World All Cap ETF (ASX: IWLD) is centred around investing in companies with better sustainability credentials than their peers. 

    The fund aims to provide investors with the performance of the MSCI World Ex Australia Custom ESG Leaders Index, before fees and expenses. The index is designed to measure the performance of global, developed market large and mid-capitalisation companies with better sustainability credentials relative to their sector peers.

    A more in-depth classification of how this screening occurs can be found in the BlackRock fact sheet. 

    The fund has risen more than 11% this year. 

    It is currently comprised of more than 600 underlying holdings and focuses on companies outside Australia. 

    Its largest weighting by sector is to: 

    Vanguard Ethically Conscious International Shares Index ETF Fun (ASX: VESG)

    This fund also employs a negative screening method to build its portfolio. 

    According to Vanguard, it excludes the securities of companies that have a specified level of business involvement in fossil fuels, nuclear power, alcohol, tobacco, cannabis, gambling, adult entertainment or weapons. 

    The index also excludes companies involved in controversial conduct related to the principles of the United Nations Global Compact.

    More in-depth information about the screening process can be found on Vanguard’s website. 

    The fund is up 11.6% so far in 2025. 

    It is an extremely diversified fund with more than 1,400 underlying holdings. 

    Its largest exposure is to: 

    • Technology (40.3%)
    • Consumer Discretionary (15.1%) 
    • Financials (14.3%).

    The post Which ethically focussed ASX ETFs have performed the best this year? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in iShares Core MSCI World All Cap ETF right now?

    Before you buy iShares Core MSCI World All Cap ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and iShares Core MSCI World All Cap ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • This ASX storage REIT’s shares surge as takeover talks confirmed

    Man with rocket wings which have flames coming out of them.

    Shares in National Storage REIT (ASX: NSR) surged almost 20% on Wednesday after the company confirmed it was in takeover talks with private equity buyers.

    The company asked for its shares to be halted from trade before the start of the session on Wednesday after The Australian reported that Brookfield Property Group and GIC Investments were running the ruler over the $3.2 billion self-storage giant.

    Company definitely in play

    National Storage initially did not confirm that talks were afoot; however, late in the trading day on Wednesday, the company confirmed that it had indeed been approached about “an unsolicited, non-binding, indicative and conditional proposal”.

    As the company said:

    Under the terms of the indicative proposal, NSR securityholders would receive $2.86 cash per stapled security on the basis that a dividend or distribution of 6 cents in respect of the financial half year ending 31 December 2025 may be paid, in which case, the cash payable per stapled security will be reduced by the amount of the dividend or distribution paid. The indicative proposal follows earlier confidential, unsolicited, non-binding and indicative proposals from the consortium and a period of negotiation including the provision of limited due diligence.

    The proposal is subject to conditions, including satisfactory due diligence and a unanimous recommendation from the National Storage board. It would also be subject to regulatory approvals, including sign-off from the Foreign Investment Review Board.

    National Storage stated that it had assessed the proposal and decided to grant the consortium the right to conduct due diligence.

    It went on to say:

    The NSR Board has also agreed to provide a period of exclusivity to the consortium ending on 7 December 2025 unless a superior proposal is received before that time and the NSR board determines to pursue it, in which case exclusivity will end at that time. The exclusivity arrangements comprise customary non-solicit, no talk, no due diligence and notification of approach obligations.

    National Storage shares closed on Wednesday up 19.5% at $2.70, but still well below the potential bid price.

    Takeover hype spills over to Abacus

    News of the takeover approach for National Storage also put a rocket under shares in Abacus Storage King (ASX: ASK), which closed 9.3% higher on Wednesday at $1.52.

    National Storage is a shareholder in Abacus, holding a stake of just under 5%, and Abacus was itself the target of takeover suitors earlier this year.

    Ki Corporation and US-listed firm Public Storage (NYSE: PSA) brought a $1.47 per security bid to the company, which was rejected in May, but left Ki Corporation with a 63.5% stake in the business.

    Abacus said at the time that its net tangible asset value was $1.73 based on an independent valuation, and hence the consortium’s bid was too low.

    The post This ASX storage REIT’s shares surge as takeover talks confirmed appeared first on The Motley Fool Australia.

    Should you invest $1,000 in National Storage REIT right now?

    Before you buy National Storage REIT shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and National Storage REIT wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Already up 67% YTD Bell Potter thinks this small cap stock can keep soaring

    Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.

    Small-cap stocks tend to exhibit increased volatility compared to well-established, blue-chip companies. 

    However, history shows that a select few of these penny stocks will grow into the mid-cap or even large-cap stocks in the future. 

    Identifying them early is the challenging part. 

    One small-cap stock to keep an eye on is Macmahon Holdings Limited (ASX: MAH). 

    It has already risen by more than 67% in 2025, and the team at Bell Potter has just bumped up its share price target on the back of a key contract win for the company. 

    Macmahon Holdings is an Australian company providing mining services across Australia and Southeast Asia. Its services cover surface and underground mining, civil construction, and resources engineering.

    At the time of writing, shares are trading for approximately $0.59; however, Bell Potter has just raised its price target, indicating potential for more growth ahead. 

    Here is the latest guidance from the broker. 

    Key contract win

    In a report released by Bell Potter on Monday, the broker stated that the company has secured an underground contract win in Indonesia. 

    The contract is for a term of 34 months, with a contract value of $36m in the first year. 

    This follows a contract win in Indonesia announced in August 2025, for an underground mine in North Sulawesi, with PT Tambang Tondano Nusajaya. 

    This contract is valued at $33m over a 32-month period.

    Bell Potter said these two contracts will partly replace the revenue lost from a previous agreement with Vault Minerals Ltd (ASX: VAU). 

    However, the broker believes this will increase exposure to underground mining, in line with the company’s strategy, which is expected to be less capital-intensive. 

    The company has delivered strong growth, and the shares have performed well in 2025, but continue to trade on just 10.5x prospective earnings.

    The company is guiding to EBIT(A) of $180m-$195m in FY26, which at the mid-point would be 9% ahead of FY25.

    Buy recommendation for this small-cap stock

    Based on this guidance, Bell Potter has increased its target price on this ASX small-cap stock to $0.65 (previously $0.50). 

    Based on yesterday’s closing price of $0.59, this indicates an upside of 10.17%. 

    This optimism is based on a combination of factors, including: 

    • Strong revenue base: FY25 secured revenue of $2.1bn, and an order book of $5.4bn provides visibility and stability.
    • Underground mining growth: Expected 50% growth over the next 2–3 years.
    • International expansion: Targeting 15% of group turnover from international work, supported by new contracts in Indonesia.
    • Competitive advantage in Indonesia: Strong existing relationships and expertise in hard-rock underground mining.

    The post Already up 67% YTD Bell Potter thinks this small cap stock can keep soaring appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Macmahon Holdings Limited right now?

    Before you buy Macmahon Holdings Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Macmahon Holdings Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.